Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TPST

Tempest Therapeutics Inc

May 14 • 04:00PM ET

2.09

+0.25 13.59 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: NVCT CUE BLRX IMNN VERU

| Held by: VXF VTI DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.84	Insider Own	43.33%	Shs Outstand	14.34M	Perf Week	6.09%
Market Cap	29.98M	Forward P/E	-	EPS next Y	-1.21	Insider Trans	3.87%	Shs Float	8.13M	Perf Month	-1.42%
Enterprise Value	30.41M	PEG	-	EPS next Q	-0.28	Inst Own	4.27%	Short Float	4.86%	Perf Quarter	-9.52%
Income	-26.26M	P/S	-	EPS this Y	78.83%	Inst Trans	11.60%	Short Ratio	1.97	Perf Half Y	-78.27%
Sales	0.00M	P/B	1.54	EPS next Y	9.70%	ROA	-83.17%	Short Interest	0.40M	Perf YTD	-27.18%
Book/sh	1.35	P/C	3.89	EPS next 5Y	48.00%	ROE	-203.63%	52W High	12.23 -82.91%	Perf Year	-68.09%
Cash/sh	0.54	P/FCF	-	EPS past 3/5Y	46.00% 76.03%	ROIC	-192.86%	52W Low	1.50 39.33%	Perf 3Y	-92.34%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.38% 9.42%	Perf 5Y	-98.91%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	65.02%	Oper. Margin	-	ATR (14)	0.17	Perf 10Y	-99.99%
Dividend Ex-Date	-	Quick Ratio	2.50	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	55.94	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.50	EPS Q/Q	80.02%	SMA20	9.08%	Beta	-1.76	Target Price	11.00
Payout	-	Debt/Eq	1.22	Sales Q/Q	-	SMA50	6.69%	Rel Volume	1.20	Prev Close	1.84
Employees	4	LT Debt/Eq	1.04	Earnings	Mar 30 BMO	SMA200	-61.12%	Avg Volume	200.69K	Price	2.09
IPO	Nov 12, 2012	Option/Short	No / Yes	EPS/Sales Surpr.	50.00% -	Trades		Volume	240,971	Change	13.59%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)